Pasithea Therapeutics Corp. (KTTA)
Data as of , from SEC Form 4 filings.
See up to 3 months of KTTA. The 7-day demo opens the 1M and 3M ranges and puts KTTA on your watchlist.
Start 7-day demoLatest KTTA insider trades
- Coastlands Capital LP - 10% OwnerOpen-market purchase$53K
Tiago Marques - OfficerOpen-market purchase$25K
About Pasithea Therapeutics Corp. (KTTA)
Pasithea Therapeutics Corp. files with the SEC under CIK 0001841330 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. A registration statement was filed on 18 November 2025. No offering has priced.
KTTA Form 4 activity by transaction type, last 90 days
No Form 4 activity for KTTA in the last 90 days.
KTTA insider transactions (Form 4)
1919 Form 4 filings on record, the earliest from Oct 27, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Coastlands Capital LP - 10% Owner | Open-market purchase | Common Stock | 100,000 | $0.53 | $53K | |
| Tiago Marques - Officer | Grant or award | Stock Option (right to buy) | 1,756,069 | $0.00 | - | |
 Lawrence Steinman - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Simon Dumesnil - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Daniel H. Schneiderman - Officer | Grant or award | Stock Option (right to buy) | 1,129,323 | $0.00 | - | |
 Kartik Krishnan - Officer | Grant or award | Stock Option (right to buy) | 1,129,323 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Alfred J. Novak - Director | Grant or award | Stock Option (right to buy) | 152,783 | $0.00 | - | |
| Tiago Marques - Officer | Open-market purchase | Common Stock | 33,333 | $0.75 | $25K | |
| Simon Dumesnil - Director | Open-market purchase | Common Stock | 33,333 | $0.75 | $25K | |
| Emer Leahy - Director | Grant or award | Common Stock | 33,333 | $0.75 | $25K | |
| Daniel H. Schneiderman - Officer | Grant or award | Common Stock | 26,667 | $0.75 | $20K | |
| Lawrence Steinman - Director | Open-market purchase | Common Stock | 133,333 | $0.75 | $100K | |
| Tiago Marques - Officer | Grant or award | Stock Option (right to buy) | 493,341 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Simon Dumesnil - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Daniel H. Schneiderman - Officer | Grant or award | Stock Option (right to buy) | 317,266 | $0.00 | - | |
| Alfred J. Novak - Director | Grant or award | Stock Option (right to buy) | 42,913 | $0.00 | - | |
| Lawrence Steinman - Director | Grant or award | Stock Option (right to buy) | 242,913 | $0.00 | - |
KTTA insider trading FAQ
What is the latest insider trade for KTTA?
Pasithea Therapeutics Corp. (KTTA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-22. The full record for KTTA runs to 19 Form 4 filings, the earliest from 2025-10-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KTTA stock?
No insider purchases of KTTA were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling KTTA stock?
No insider sales of KTTA were filed in the last 90 days.
Where can I see KTTA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KTTA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Coastlands Capital LP view on EDGAR
- - Tiago Marques view on EDGAR
- - Lawrence Steinman view on EDGAR
- - Simon Dumesnil view on EDGAR
- - Daniel H. Schneiderman view on EDGAR
- - Kartik Krishnan view on EDGAR
- - Emer Leahy view on EDGAR
- - Alfred J. Novak view on EDGAR
- - Tiago Marques view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KTTA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KTTA with a 7-day demo
- KTTA on your watchlist
- Every KTTA Form 4 filing on record
- Up to 3 months of KTTA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
